[
  {
    "report_key": "2026:q2",
    "period_label": "2026 Q2",
    "date": "2026-08-06",
    "title": "Kvartalsrapport Q2 2026",
    "original_title": "Immunovia publicerar Delårsrapport april-juni 2026",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b2811f5df23ff37a6e07020eafddb689b&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
        "title": "Kvartalsrapport Q2 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ae1f417bd344855d4ceb5689dc8cbb99a",
        "date": "2026-08-06",
        "period": "2026-q2",
        "form_type": "interim-report",
        "report_key": "2026:q2",
        "filename": "Immunovia_Delarsrapport_Q2_2026.pdf",
        "text_chars": 54040,
        "sha256": "dd64257dad51d8e061ea554c48d6f4705c367b942e47569c3f24b02b0c4de2dc",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
            "chars": 54040
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2026:q1",
    "period_label": "2026 Q1",
    "date": "2026-05-07",
    "title": "Kvartalsrapport Q1 2026",
    "original_title": "Rättelse: Immunovia publicerar Delårsrapport januari-mars 2026",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b1a6666ce1414ec4a14c8c9fa1bf0d3fd&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
        "title": "Kvartalsrapport Q1 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a9f26903c3283771aae8384f7671d2965",
        "date": "2026-05-07",
        "period": "2026-q1",
        "form_type": "interim-report",
        "report_key": "2026:q1",
        "filename": "Immunovia_Delarsrapport_Q1_2026.pdf",
        "text_chars": 51299,
        "sha256": "82e9edf4b17f2d80be0d79e78b699609f88a57293279f46a189ff73ed86cb4b4",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
            "chars": 51299
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:annual",
    "period_label": "2025 Årsredovisning",
    "date": "2026-04-10",
    "title": "Årsredovisning 2025",
    "original_title": "Immunovia publicerar årsredovisningen för 2025",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b4f471ae9e79c966a43e7d980eb4e12c3&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2025,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2025",
        "title": "Årsredovisning 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a003a0716b3c489d57e20b93cb41e4694",
        "date": "2026-04-10",
        "period": "2025-annual",
        "form_type": "annual-report",
        "report_key": "2025:annual",
        "filename": "Immunovia_AB_publ_Arsredovisning_2025.pdf",
        "text_chars": 180734,
        "sha256": "5835d188655b3c9f74e66c3ca06c35c44edf4fe2635245fa7978fbb34fd49ac5",
        "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
            "chars": 179700
          },
          {
            "number": 2,
            "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
            "chars": 1032
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q4",
    "period_label": "2025 Q4",
    "date": "2026-02-24",
    "title": "Kvartalsrapport Q4 2025",
    "original_title": "Immunovia publicerar Bokslutskommuniké 2025",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b95025f0bd10ccc70b2fd8ceccd20986a&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2025,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
        "title": "Kvartalsrapport Q4 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a9a34f3722386ab8c29d882a04d530924",
        "date": "2026-02-24",
        "period": "2025-q4",
        "form_type": "year-end-report",
        "report_key": "2025:q4",
        "filename": "Bokslutskommunike_2025.pdf",
        "text_chars": 52683,
        "sha256": "2c0698add5bcd649088d1f7d8281bcf564f857711ae658b11c6ef51fe29ac391",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
            "chars": 52683
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q3",
    "period_label": "2025 Q3",
    "date": "2025-11-26",
    "title": "Kvartalsrapport Q3 2025",
    "original_title": "Immunovia publicerar Delårsrapport juli-september 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b9623e7e118c752eb34a564057ac11d47&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
        "title": "Kvartalsrapport Q3 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a54474f94e81f22f8f79db9eea5345820",
        "date": "2025-11-26",
        "period": "2025-q3",
        "form_type": "interim-report",
        "report_key": "2025:q3",
        "filename": "Immunovia_Delarsrapport_Q3_2025.pdf",
        "text_chars": 56928,
        "sha256": "b271e34cd6d179a57b367446b5b96b4cc5b4112ae24b7946235b01bd68a801dd",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
            "chars": 56928
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q2",
    "period_label": "2025 Q2",
    "date": "2025-08-28",
    "title": "Kvartalsrapport Q2 2025",
    "original_title": "Immunovia publicerar Delårsrapport januari-juni 2025",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b8b0daac652727508919c33b0b9551583&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
        "title": "Kvartalsrapport Q2 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a34ac50a6b43e88fafab56acaa607b867",
        "date": "2025-08-28",
        "period": "2025-q2",
        "form_type": "interim-report",
        "report_key": "2025:q2",
        "filename": "Immunovia_Delarsrapport_Q2_2025.pdf",
        "text_chars": 52590,
        "sha256": "cdfeedad1fe434d611f256fabfc55b97bcec98532c0badfbc45ba8a722de0883",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
            "chars": 52590
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q1",
    "period_label": "2025 Q1",
    "date": "2025-05-14",
    "title": "Kvartalsrapport Q1 2025",
    "original_title": "Immunovia publicerar Delårsrapport januari-mars 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b41388f6bed50cdb8c4704cb71e9c73c6&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
        "title": "Kvartalsrapport Q1 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a4c207209390b4129817aaef9aed0e724",
        "date": "2025-05-14",
        "period": "2025-q1",
        "form_type": "interim-report",
        "report_key": "2025:q1",
        "filename": "Immunovia_Delarsrapport_Q1_2025.pdf",
        "text_chars": 49052,
        "sha256": "0998c3898b3b41de80babf449ac83e5b37f5faa319bc1318556c743722283306",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
            "chars": 49052
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:annual",
    "period_label": "2024 Årsredovisning",
    "date": "2025-04-02",
    "title": "Årsredovisning 2024",
    "original_title": "Immunovia publicerar årsredovisningen för 2024",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bc44d41fa956d8be3c0465865957090ee&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2024,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2024",
        "title": "Årsredovisning 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ad8f82bcabe6b205567357ba5b348dd01",
        "date": "2025-04-02",
        "period": "2024-annual",
        "form_type": "annual-report",
        "report_key": "2024:annual",
        "filename": "04010960.pdf",
        "text_chars": 171458,
        "sha256": "a4515cc4b07797264935dbcff2789cfdf6bf2969bf78883aebc2bec5143746bd",
        "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
            "chars": 171458
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q4",
    "period_label": "2024 Q4",
    "date": "2025-02-25",
    "title": "Kvartalsrapport Q4 2024",
    "original_title": "Immunovia publicerar Bokslutskommuniké 2024",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b212d1c22005999027287c160918d11a0&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2024,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
        "title": "Kvartalsrapport Q4 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/abe1f005fa7d4e8f7d69c5443ceb81adf",
        "date": "2025-02-25",
        "period": "2024-q4",
        "form_type": "year-end-report",
        "report_key": "2024:q4",
        "filename": "02241926.pdf",
        "text_chars": 52992,
        "sha256": "05a51c33048ff12a3e5f66bd75db3a908aaa5cb10acc4deee349495cf05e0f99",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
            "chars": 52992
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q3",
    "period_label": "2024 Q3",
    "date": "2024-11-27",
    "title": "Kvartalsrapport Q3 2024",
    "original_title": "Immunovia publicerar Delårsrapport januari-september 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b8b53f31aecfb743c65abdf35b7833931&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
        "title": "Kvartalsrapport Q3 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/acd18c866d911da5e4edb17009d06304a",
        "date": "2024-11-27",
        "period": "2024-q3",
        "form_type": "interim-report",
        "report_key": "2024:q3",
        "filename": "11263202.pdf",
        "text_chars": 52618,
        "sha256": "3a806c9f778c8ff2f04b94fd3a6cadfaaae0eedeae12f90fae764ae9eacf0266",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
            "chars": 52618
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q2",
    "period_label": "2024 Q2",
    "date": "2024-08-05",
    "title": "Kvartalsrapport Q2 2024",
    "original_title": "Immunovia publicerar Delårsrapport januari-juni 2024",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b25c580428d5814df1e00619cdca80c88&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
        "title": "Kvartalsrapport Q2 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/af0c0fc60f1be8e297da6c1197aa1fd20",
        "date": "2024-08-05",
        "period": "2024-q2",
        "form_type": "interim-report",
        "report_key": "2024:q2",
        "filename": "08041669.pdf",
        "text_chars": 51580,
        "sha256": "df5a5c22c0fd818bab44b1bf857e17f3598c490f53539889486bf2758bb0e91a",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
            "chars": 51580
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q1",
    "period_label": "2024 Q1",
    "date": "2024-04-29",
    "title": "Kvartalsrapport Q1 2024",
    "original_title": "Immunovia publicerar Delårsrapport januari-mars 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b4d0abd112c5a082193b9e1be811299f4&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
        "title": "Kvartalsrapport Q1 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a4e47857722f4af0dda08663c0e7fa1a0",
        "date": "2024-04-29",
        "period": "2024-q1",
        "form_type": "interim-report",
        "report_key": "2024:q1",
        "filename": "04289478.pdf",
        "text_chars": 47070,
        "sha256": "5d01116aeaa35137c5bc6e02fba92f7dc66eaaf2032bf2cd528e3d0173bc83f4",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
            "chars": 47070
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:annual",
    "period_label": "2023 Årsredovisning",
    "date": "2024-04-29",
    "title": "Årsredovisning 2023",
    "original_title": "Immunovia publicerar årsredovisningen för 2023",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bbd4042338269ccc77bd024770608b8d7&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2023,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2023",
        "title": "Årsredovisning 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a70dcaddefd57dbbd8b33a06aa4bc8ce2",
        "date": "2024-04-29",
        "period": "2023-annual",
        "form_type": "annual-report",
        "report_key": "2023:annual",
        "filename": "04299763.pdf",
        "text_chars": 190758,
        "sha256": "d777c5ae5528db58596f43a25d96705db22e4de68e60408f17d23268cefb6319",
        "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
            "chars": 178828
          },
          {
            "number": 2,
            "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
            "chars": 11928
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q4",
    "period_label": "2023 Q4",
    "date": "2024-02-21",
    "title": "Kvartalsrapport Q4 2023",
    "original_title": "Immunovia publicerar Bokslutskommuniké 2023",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b91785184b96209906ea0184ec9195341&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2023,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
        "title": "Kvartalsrapport Q4 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a6a47d32a9fd60e7b8bd200d032a951f0",
        "date": "2024-02-21",
        "period": "2023-q4",
        "form_type": "year-end-report",
        "report_key": "2023:q4",
        "filename": "02202332.pdf",
        "text_chars": 57447,
        "sha256": "20dcbea82e241e3a7bedc430d19d1720115f11eee5508a11099b01cb5c79b86f",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
            "chars": 57447
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q3",
    "period_label": "2023 Q3",
    "date": "2023-11-09",
    "title": "Kvartalsrapport Q3 2023",
    "original_title": "Immunovia publicerar Delårsrapport januari-september 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bdaf84d6ee2ea08b443bd4c0baa498b72&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
        "title": "Kvartalsrapport Q3 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aec57324595315300aeeaee2a72ce03c8",
        "date": "2023-11-09",
        "period": "2023-q3",
        "form_type": "interim-report",
        "report_key": "2023:q3",
        "filename": "11081246.pdf",
        "text_chars": 56339,
        "sha256": "5081fce965b0350cac4df4eaad2f897e4684914745bee61c519ec6e2a962c46d",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
            "chars": 56339
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q2",
    "period_label": "2023 Q2",
    "date": "2023-08-30",
    "title": "Kvartalsrapport Q2 2023",
    "original_title": "Immunovia publicerar Delårsrapport januari-juni 2023",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b371e6323aef2194d84e4c7ecc2d89e30&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
        "title": "Kvartalsrapport Q2 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aef1296542205e39180d2c63a5aa2de4b",
        "date": "2023-08-30",
        "period": "2023-q2",
        "form_type": "interim-report",
        "report_key": "2023:q2",
        "filename": "08294671.pdf",
        "text_chars": 55030,
        "sha256": "d3df7868ec951e4987f7a56ad78374700ecc020c9947dc06d022301d0b5ac249",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
            "chars": 55030
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q1",
    "period_label": "2023 Q1",
    "date": "2023-05-23",
    "title": "Kvartalsrapport Q1 2023",
    "original_title": "Immunovia publicerar Delårsrapport januari-mars 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b81a20371a4ce5834b89f9ae6b27303b4&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
        "title": "Kvartalsrapport Q1 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a624425c262bab7d0258e72e8ab48e1f2",
        "date": "2023-05-23",
        "period": "2023-q1",
        "form_type": "interim-report",
        "report_key": "2023:q1",
        "filename": "05220986.pdf",
        "text_chars": 50387,
        "sha256": "dcf8f047fbd1ff2984ea9e64777cc635cc14a2016082b71926900a213fd51942",
        "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
            "chars": 50387
          }
        ]
      }
    ],
    "alternatives": []
  }
]